Proteome Sciences plc
PMSNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,794 | $11,245 | $12,740 | $10,653 |
| - Cash | $1,128 | $2,027 | $3,994 | $2,387 |
| + Debt | $14,522 | $13,475 | $11,915 | $11,687 |
| Enterprise Value | $25,188 | $22,693 | $20,661 | $19,953 |
| Revenue | $4,887 | $5,028 | $23,736,000 | $22,593,000 |
| % Growth | -2.8% | -100% | 5.1% | – |
| Gross Profit | $670 | $1,647 | $4,767 | $2,960 |
| % Margin | 13.7% | 32.8% | 0% | 0% |
| EBITDA | -$1,515 | -$1,137 | $1,834 | $625 |
| % Margin | -31% | -22.6% | 0% | 0% |
| Net Income | -$3,406 | -$2,443 | $1,325 | $72 |
| % Margin | -69.7% | -48.6% | 0% | 0% |
| EPS Diluted | -0.012 | -0.008 | 0.004 | 0 |
| % Growth | -38.6% | -293% | 2,050% | – |
| Operating Cash Flow | -$826 | -$481 | $3,882,000 | $10,522,000 |
| Capital Expenditures | -$224 | -$237 | -$1,746,000 | -$1,720,000 |
| Free Cash Flow | -$1,050 | -$718 | $2,136,000 | $8,802,000 |